Novum Pharmaceutical Research
Novum Pharmaceutical Research Services is a distinguished contract research organization (CRO) with over 50 years of experience in delivering comprehensive clinical research solutions to the global biotech and pharmaceutical industries. Acquired by Lambda Therapeutic Research in 2019, Novum operates under a unified brand, leveraging a vast network and substantial therapeutic expertise to effectively manage multi-centric clinical programs across various therapeutic areas.
With a robust track record of FDA approvals, Novum offers end-to-end services that encompass early-phase to late-phase clinical trial management, scientific affairs, and bioanalytical support. The company is committed to upholding the highest standards of integrity and innovation while consistently exceeding client expectations in drug development programs.
Generated from the website



